Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab Switch Assessment in RA
NCT01004432Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2009
- Primary completion
- Jul 2013
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 3 trial of golimumab in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started Dec 2009; status: completed.
02
Drugs
golimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01004432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01004432.